These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1509 related items for PubMed ID: 19251756

  • 1. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX, Ill-Raga G, Bravo R, Nakaya T, de Fabritiis G, Coma M, Miscione GP, Villà-Freixa J, Suzuki T, Fernàndez-Busquets X, Valverde MA, de Strooper B, Muñoz FJ.
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [Abstract] [Full Text] [Related]

  • 2. Methylglyoxal produced by amyloid-β peptide-induced nitrotyrosination of triosephosphate isomerase triggers neuronal death in Alzheimer's disease.
    Tajes M, Eraso-Pichot A, Rubio-Moscardó F, Guivernau B, Ramos-Fernández E, Bosch-Morató M, Guix FX, Clarimón J, Miscione GP, Boada M, Gil-Gómez G, Suzuki T, Molina H, Villà-Freixa J, Vicente R, Muñoz FJ.
    J Alzheimers Dis; 2014 May; 41(1):273-88. PubMed ID: 24614897
    [Abstract] [Full Text] [Related]

  • 3. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J, Levy M, Dickson DW, Potter H.
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [Abstract] [Full Text] [Related]

  • 4. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease.
    Page G, Rioux Bilan A, Ingrand S, Lafay-Chebassier C, Pain S, Perault Pochat MC, Bouras C, Bayer T, Hugon J.
    Neuroscience; 2006 Nov; 139(4):1343-54. PubMed ID: 16581193
    [Abstract] [Full Text] [Related]

  • 5. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
    Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, Weidensteiner C, von Kienlin M, Ozmen L.
    Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
    [Abstract] [Full Text] [Related]

  • 6. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM, Pérez M, Puig B, Gich I, Lim F, Cuadrado M, Sesma T, Catena S, Sánchez B, Nieto M, Gómez-Ramos P, Morán MA, Cabodevilla F, Samaranch L, Ortiz L, Pérez A, Ferrer I, Avila J, Gómez-Isla T.
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [Abstract] [Full Text] [Related]

  • 7. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW, Ogino K, Shimabuku A, Taki T, Nakashima H, Ishihara T, Kitamoto T.
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
    Pérez M, Ribe E, Rubio A, Lim F, Morán MA, Ramos PG, Ferrer I, Isla MT, Avila J.
    Neuroscience; 2005 Jun; 130(2):339-47. PubMed ID: 15664690
    [Abstract] [Full Text] [Related]

  • 9. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
    Härtig W, Goldhammer S, Bauer U, Wegner F, Wirths O, Bayer TA, Grosche J.
    J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
    [Abstract] [Full Text] [Related]

  • 10. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC, Ittner LM, Gehrig P, Nergenau D, Shepherd C, Halliday G, Götz J.
    Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
    [Abstract] [Full Text] [Related]

  • 11. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.
    Lafay-Chebassier C, Paccalin M, Page G, Barc-Pain S, Perault-Pochat MC, Gil R, Pradier L, Hugon J.
    J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364
    [Abstract] [Full Text] [Related]

  • 12. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
    Pan X, Gong N, Zhao J, Yu Z, Gu F, Chen J, Sun X, Zhao L, Yu M, Xu Z, Dong W, Qin Y, Fei G, Zhong C, Xu TL.
    Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653
    [Abstract] [Full Text] [Related]

  • 13. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
    Samura E, Shoji M, Kawarabayashi T, Sasaki A, Matsubara E, Murakami T, Wuhua X, Tamura S, Ikeda M, Ishiguro K, Saido TC, Westaway D, St George Hyslop P, Harigaya Y, Abe K.
    Brain Res; 2006 Jun 13; 1094(1):192-9. PubMed ID: 16713590
    [Abstract] [Full Text] [Related]

  • 14. [Tau, amyloid and Alzheimer's disease].
    Olesen OF.
    Ugeskr Laeger; 1994 Feb 21; 156(8):1116-7, 1121-4. PubMed ID: 8116089
    [Abstract] [Full Text] [Related]

  • 15. Granular tau oligomers as intermediates of tau filaments.
    Maeda S, Sahara N, Saito Y, Murayama M, Yoshiike Y, Kim H, Miyasaka T, Murayama S, Ikai A, Takashima A.
    Biochemistry; 2007 Mar 27; 46(12):3856-61. PubMed ID: 17338548
    [Abstract] [Full Text] [Related]

  • 16. Effects of Tau on the activity of triose phosphate isomerase (TPI) in brain cells.
    Park SA, Park HW, Kim NH, Kim YH, Kwak MJ, Shin JS, Kim CW.
    Neurochem Int; 2010 Jul 27; 56(8):886-92. PubMed ID: 20359515
    [Abstract] [Full Text] [Related]

  • 17. The amyloid peptide and its precursor in Alzheimer's disease.
    Octave JN.
    Rev Neurosci; 1995 Jul 27; 6(4):287-316. PubMed ID: 8845971
    [Abstract] [Full Text] [Related]

  • 18. Lack of oestrogen protection in amyloid-mediated endothelial damage due to protein nitrotyrosination.
    Coma M, Guix FX, Uribesalgo I, Espuña G, Solé M, Andreu D, Muñoz FJ.
    Brain; 2005 Jul 27; 128(Pt 7):1613-21. PubMed ID: 15817516
    [Abstract] [Full Text] [Related]

  • 19. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS, Jiang P, Aznavour N, Tong XK, Buttini M, Descarries L, Hamel E.
    Neuroscience; 2005 Jul 27; 132(1):73-86. PubMed ID: 15780468
    [Abstract] [Full Text] [Related]

  • 20. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
    Duyckaerts C, Perruchini C, Lebouvier T, Potier MC.
    Bull Acad Natl Med; 2008 Feb 27; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.